GLP-3R
GLP-3R Price range: $90.00 through $270.00
Back to products

CJC-1295 No DAC

$80.00

Research involving CJC-1295 No DAC commonly focuses on biochemical signaling pathways related to metabolic regulation, physiological adaptation, and endocrine-response mechanisms. Experimental investigations may include evaluation of receptor activity, hormone-related communication systems, and comparative peptide signaling behavior depending on dosage parameters, study methodology, and biological models employed during research.

Category:
Description

CJC-1295 No DAC

CJC-1295 No DAC is a synthetic peptide developed for laboratory and research applications involving growth hormone signaling, endocrine regulation, and metabolic pathway analysis. As a modified growth hormone-releasing hormone (GHRH) analog without Drug Affinity Complex (DAC), this peptide has been investigated in controlled scientific environments for its interaction with receptor-mediated hormonal signaling and physiological adaptation mechanisms.

Research Context

CJC-1295 No DAC is primarily studied in preclinical and translational research settings to evaluate pathways associated with endogenous growth hormone activity and endocrine communication systems. Due to its shorter active duration compared to DAC-modified variants, researchers commonly investigate its pulsatile signaling behavior and interaction with growth hormone release pathways under controlled laboratory conditions.

Research Overview

Research involving CJC-1295 No DAC commonly focuses on biochemical signaling pathways related to metabolic regulation, physiological adaptation, and endocrine-response mechanisms. Experimental investigations may include evaluation of receptor activity, hormone-related communication systems, and comparative peptide signaling behavior depending on dosage parameters, study methodology, and biological models employed during research.

Key Research Focus Areas

  • Growth Hormone Signaling: Investigation of receptor-mediated hormonal communication and endogenous signaling pathways.
  • Endocrine Regulation: Exploration of biochemical systems associated with physiological adaptation and metabolic response activity.
  • Metabolic Research: Research involving energy utilization and hormone-related signaling mechanisms.
  • Comparative Peptide Analysis: Evaluation alongside related growth hormone-releasing research compounds.
  • Pulsatile Signaling Studies: Investigation of short-acting peptide signaling activity and receptor-response behavior.

Important Compliance and Safety Information

This peptide is intended solely for research purposes and must be handled with appropriate laboratory precautions. Researchers and institutions are responsible for complying with all applicable local, regional, and national regulations governing peptide handling, storage, and investigational use.

All procedures involving CJC-1295 No DAC should be conducted by qualified personnel within properly equipped laboratory environments utilizing suitable containment measures and institutional biosafety standards.

For research use only. Not for human or animal consumption.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 No DAC”

Your email address will not be published. Required fields are marked *

Shipping and Delivery

MAECENAS IACULIS

Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.

ADIPISCING CONVALLIS BULUM

  • Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
  • Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
  • Diam parturient dictumst parturient scelerisque nibh lectus.

Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.